Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Alzheimer's Disease”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Study completedNCT05063539
What this trial is testing

LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 327
Early research (Phase 1)Ended earlyNCT01677572
What this trial is testing

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 197
Not applicableStudy completedNCT01630525
What this trial is testing

" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University Hospital, Bordeaux 83
Testing effectiveness (Phase 2)WithdrawnNCT05986721
What this trial is testing

Clinical Trial of AGB101 for Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio
Not applicableUnknownNCT04851496
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 80
Testing effectiveness (Phase 2)Looking for participantsNCT06957418
What this trial is testing

Alzheimer's Tau Platform: Master Protocol

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease
Paul S. Aisen 900
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Not applicableUnknownNCT03901261
What this trial is testing

Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease (TriAL21)

Who this might be right for
Down SyndromeAlzheimer Disease
Institut Jerome Lejeune 200
Not applicableStudy completedNCT04928976
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Not applicableUnknownNCT04992975
What this trial is testing

Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study

Who this might be right for
Prodromal Alzheimer's DiseaseMild Cognitive Impairment
Nottingham University Hospitals NHS Trust 40
Testing effectiveness (Phase 2)Study completedNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Not applicableUnknownNCT04937959
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

Who this might be right for
Alzheimer DiseaseAlzheimer's Disease (Incl Subtypes)Preclinical Alzheimer's Disease+3 more
Novoic Limited 40
Large-scale testing (Phase 3)Ended earlyNCT02956486
What this trial is testing

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 2,212
Testing effectiveness (Phase 2)Looking for participantsNCT04804241
What this trial is testing

Senicapoc in Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of California, Davis 55
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 304
Large-scale testing (Phase 3)Ended earlyNCT03443973
What this trial is testing

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 975
Testing effectiveness (Phase 2)Study completedNCT03234686
What this trial is testing

Deferiprone to Delay Dementia (The 3D Study)

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's DiseaseMild Alzheimer's Disease
Neuroscience Trials Australia 81
Not applicableEnded earlyNCT04294888
What this trial is testing

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentAging
Massachusetts General Hospital 4
Not applicableUnknownNCT04137926
What this trial is testing

Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 360
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Next Page